Home Cart 0 Sign in  
X

[ CAS No. 28466-26-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 28466-26-4
Chemical Structure| 28466-26-4
Chemical Structure| 28466-26-4
Structure of 28466-26-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 28466-26-4 ]

Related Doc. of [ 28466-26-4 ]

Alternatived Products of [ 28466-26-4 ]

Product Details of [ 28466-26-4 ]

CAS No. :28466-26-4 MDL No. :MFCD01693729
Formula : C3H5N3 Boiling Point : -
Linear Structure Formula :- InChI Key :AXINVSXSGNSVLV-UHFFFAOYSA-N
M.W : 83.09 Pubchem ID :78035
Synonyms :

Calculated chemistry of [ 28466-26-4 ]

Physicochemical Properties

Num. heavy atoms : 6
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 22.99
TPSA : 54.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.16
Log Po/w (XLOGP3) : -1.09
Log Po/w (WLOGP) : 0.0
Log Po/w (MLOGP) : -1.13
Log Po/w (SILICOS-IT) : 0.56
Consensus Log Po/w : -0.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.29
Solubility : 43.1 mg/ml ; 0.519 mol/l
Class : Very soluble
Log S (Ali) : 0.43
Solubility : 224.0 mg/ml ; 2.7 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.76
Solubility : 14.3 mg/ml ; 0.173 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.2

Safety of [ 28466-26-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P403+P233-P405-P501 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 28466-26-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 28466-26-4 ]
  • Downstream synthetic route of [ 28466-26-4 ]

[ 28466-26-4 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 2075-46-9 ]
  • [ 28466-26-4 ]
YieldReaction ConditionsOperation in experiment
100% With palladium 10% on activated carbon; hydrogen In methanol at 25℃; for 12 h; Under hydrogen (1 atm), to a solution of 4-nitropyrazole (1.13 g, 10 mmol) in methanol (10 mL) was added 10percent Pd—C (0.1 g). The mixture was stirred at 25° C. for 12 hours, and then filtrated, the filtrate was concentrated under reduced pressure to give compound 31-a (860 mg, yield: 100percent), which was used directly for the next step without purification.
100% With palladium 10% on activated carbon; hydrogen In ethanol at 20℃; 5.0g 4-nitropyrazole was dissolved in 160mL of ethanol and 0.8g of 10percent Pd/C was added. The reaction was subjected to hydrogen and reacted overnight at room temperature. TLC was used to monitor reaction completion. By celite was filtered off Pd/C. Ethanol solvent was evaporated to give 3.6g of the pure intermediate 8 as a red solid, quantitative reaction.
99% With palladium 10% on activated carbon; hydrogen In methanol for 16 h; A suspension of 4-nitro-1H-pyrazole (2.05 g, 18.13 mmol), and Pd/C (10percent w/w palladium on activated carbon, 0.96 g, 0.90 mmol) in MeOH (20 mL) was stirred under H2 atmosphere (balloon) for 16 h. The reaction mixture was filtered through Celite, rinsed with MeOH (3x 30 mL) and concentrated, affording 1.50 g of 1H-pyrazol-4- amine (pale pink solid, 99percent yield). HPLC-MS (Method H): Ret, 1.16 min; ESI+-MS m/z: 84 (M+1).
95% With hydrogen In ethanol at 20℃; for 3 h; Compound Ia (15.0 g, 133 mmol) was added to a suspension of palladium on carbon 10percent (7.0 g, 6.65 mmol) in ethanol (100 mL). The mixture was shaken for 3 hours under hydrogen pressure (40 psi) at room temperature. The catalyst was removed by filtration through a pad of Celite.(R). and the solvent was evaporated. Compound Ib was obtained as a burgundy oil (10.5 g, 126 mmol, 95percent) which was used in the following step without purification; GC/MS: m/z = 83 (100percent).
49% With hydrogen In ethanol A mixture of 4-nitro-l/f-pyrazole (1.13 g, 10 mmol), Pd/C (10percent, 57 mg) in ethanol (20 mL) was hydrogenated at 20-30 psi on a parr apparatu overnight. The reaction mixture was filtered through celite, washed with ethanol (10 mL). The filtrate was concentrated to get desired compound 0113-42 (404 mg, 49percent) as a brown solid. LC-MS: 84 [M+l]+; 1H-NMR (400 MHz, DMSO-d6) δ 3.11 (br s, 2H), 6.99 (s, 2H), 11.92 (s, IH).
3.6 g With palladium 10% on activated carbon; hydrogen In ethanol at 20℃; Dissolving 5.0 g of 4-nitropyrazole in 160 mL of ethanol, and then adding 0.8 g of 10 wtpercent Pd/C to the above solution; Hydrogen was introduced into the reaction solution and allowed to react overnight at room temperature; after the TLC detection reaction was completed, the insoluble matter was filtered off with diatomaceous earth; Evaporation of the ethanol solvent gave pure intermediate 2 as a red solid 3.6 g.

Reference: [1] Patent: US2015/336982, 2015, A1, . Location in patent: Paragraph 0252; 0253
[2] ChemMedChem, 2016, p. 1695 - 1699
[3] Patent: CN105418616, 2016, A, . Location in patent: Paragraph 0118; 0119
[4] Organic and Biomolecular Chemistry, 2013, vol. 11, # 3, p. 395 - 399
[5] Patent: WO2017/178510, 2017, A1, . Location in patent: Page/Page column 297
[6] Patent: WO2006/44821, 2006, A1, . Location in patent: Page/Page column 23
[7] Patent: WO2010/75542, 2010, A1, . Location in patent: Page/Page column 73
[8] Chemische Berichte, 1904, vol. 37, p. 3501
[9] Journal of the Chemical Society, 1945, p. 114
[10] Journal of the Chemical Society, 1925, vol. 127, p. 2939
[11] Journal of Medicinal Chemistry, 2005, vol. 48, # 18, p. 5780 - 5793
[12] Patent: US6531475, 2003, B1,
[13] Patent: US6514982, 2003, B1,
[14] Patent: WO2007/99326, 2007, A1, . Location in patent: Page/Page column 108-109
[15] Patent: WO2008/8375, 2008, A2, . Location in patent: Page/Page column 83
[16] Patent: WO2009/93012, 2009, A1, . Location in patent: Page/Page column 20; 35
[17] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4350 - 4364
[18] Patent: WO2012/52459, 2012, A1, . Location in patent: Page/Page column 38-39
[19] Patent: WO2012/52458, 2012, A1, . Location in patent: Page/Page column 34
[20] Patent: WO2012/110986, 2012, A1, . Location in patent: Page/Page column 52-53
[21] Patent: WO2014/194242, 2014, A2, . Location in patent: Paragraph 00603-0605
[22] Patent: CN108864057, 2018, A, . Location in patent: Paragraph 0105; 0206-0208
  • 2
  • [ 2075-46-9 ]
  • [ 28466-26-4 ]
  • [ 63680-90-0 ]
Reference: [1] Patent: US2015/111938, 2015, A1, . Location in patent: Paragraph 0018; 0019
[2] Patent: US2015/112073, 2015, A1, . Location in patent: Paragraph 0019-0020
[3] Patent: US2015/112074, 2015, A1, . Location in patent: Paragraph 0020; 0021
  • 3
  • [ 2075-46-9 ]
  • [ 28466-26-4 ]
Reference: [1] Patent: US2015/112076, 2015, A1, . Location in patent: Paragraph 0008; 0020; 0021
  • 4
  • [ 2075-46-9 ]
  • [ 28466-26-4 ]
Reference: [1] Tetrahedron Letters, 2017, vol. 58, # 1, p. 82 - 86
  • 5
  • [ 116008-52-7 ]
  • [ 28466-26-4 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1927, vol. 457, p. 292
  • 6
  • [ 7647-01-0 ]
  • [ 40769-81-1 ]
  • [ 28466-26-4 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1902, vol. 323, p. 281
  • 7
  • [ 28466-26-4 ]
  • [ 3469-69-0 ]
Reference: [1] Chemische Berichte, 1904, vol. 37, p. 3501
  • 8
  • [ 2075-46-9 ]
  • [ 28466-26-4 ]
  • [ 63680-90-0 ]
Reference: [1] Patent: US2015/111938, 2015, A1, . Location in patent: Paragraph 0018; 0019
[2] Patent: US2015/112073, 2015, A1, . Location in patent: Paragraph 0019-0020
[3] Patent: US2015/112074, 2015, A1, . Location in patent: Paragraph 0020; 0021
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 28466-26-4 ]

Amines

Chemical Structure| 4331-28-6

[ 4331-28-6 ]

1H-Pyrazol-4-amine hydrochloride

Similarity: 0.97

Chemical Structure| 69843-13-6

[ 69843-13-6 ]

1-Methyl-1H-pyrazol-4-amine

Similarity: 0.84

Chemical Structure| 1063734-49-5

[ 1063734-49-5 ]

1-Methyl-1H-pyrazol-4-amine dihydrochloride

Similarity: 0.82

Chemical Structure| 127107-23-7

[ 127107-23-7 ]

1-Methyl-1H-pyrazol-4-amine hydrochloride

Similarity: 0.82

Chemical Structure| 1896159-87-7

[ 1896159-87-7 ]

N,1-Dimethyl-1H-pyrazol-4-amine dihydrochloride

Similarity: 0.78

Related Parent Nucleus of
[ 28466-26-4 ]

Pyrazoles

Chemical Structure| 4331-28-6

[ 4331-28-6 ]

1H-Pyrazol-4-amine hydrochloride

Similarity: 0.97

Chemical Structure| 69843-13-6

[ 69843-13-6 ]

1-Methyl-1H-pyrazol-4-amine

Similarity: 0.84

Chemical Structure| 1063734-49-5

[ 1063734-49-5 ]

1-Methyl-1H-pyrazol-4-amine dihydrochloride

Similarity: 0.82

Chemical Structure| 127107-23-7

[ 127107-23-7 ]

1-Methyl-1H-pyrazol-4-amine hydrochloride

Similarity: 0.82

Chemical Structure| 1896159-87-7

[ 1896159-87-7 ]

N,1-Dimethyl-1H-pyrazol-4-amine dihydrochloride

Similarity: 0.78